Cannabis Extract Shows Anti-Inflammatory Effects in a Rat Model of Dermatitis

Cannabis sativa extract demonstrated anti-inflammatory activity in a rat model of dermatitis, supporting potential applications for inflammatory skin conditions.

Wolińska, Renata et al.·Pharmaceuticals (Basel·2025·Preliminary Evidencepreclinical
RTHC-07963PreclinicalPreliminary Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
preclinical
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Cannabis extract reduced inflammation markers in a DNCB-induced dermatitis rat model, providing preclinical evidence for its potential use in inflammatory skin conditions like atopic dermatitis.

Key Numbers

Used DNCB-induced dermatitis model in rats — specific group sizes and dosing would be in the full methods.

How They Did This

Preclinical study using a 2,4-dinitrochlorobenzene (DNCB)-induced dermatitis model in rats to evaluate the anti-inflammatory activity of Cannabis sativa L. extract.

Why This Research Matters

CBD-containing skin products are booming, but clinical evidence is limited. Preclinical studies like this help establish whether the anti-inflammatory claims have biological plausibility before moving to human trials.

The Bigger Picture

The topical CBD market is growing rapidly for conditions like eczema and psoriasis. Preclinical evidence establishing mechanisms of action is essential for moving from anecdotal reports to evidence-based dermatology.

What This Study Doesn't Tell Us

Animal model may not translate to human skin conditions. DNCB-induced dermatitis is a simplified model of complex human inflammatory skin diseases. Extract composition may vary from commercial products.

Questions This Raises

  • ?Which specific compounds in the cannabis extract drive the anti-inflammatory effect?
  • ?Would purified CBD alone be as effective as whole-plant extract?

Trust & Context

Key Stat:
Evidence Grade:
Animal study providing mechanistic support — useful for understanding potential but not directly applicable to human treatment decisions.
Study Age:
Recent preclinical work addressing the evidence gap behind the rapidly growing CBD skincare market.
Original Title:
Anti-Inflammatory Activity of Cannabis sativa L. Extract in 2,4-Dinitrochlorobenzene-Induced Dermatitis in Rats.
Published In:
Pharmaceuticals (Basel, Switzerland), 18(3) (2025)
Database ID:
RTHC-07963

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Does this mean CBD creams work for eczema?

This animal study supports the biological plausibility, but human clinical trials are needed before making treatment claims. The rat model is a simplified version of human skin conditions.

Is whole cannabis extract better than pure CBD for skin?

This study tested whole extract. Whether purified CBD or the full spectrum of cannabis compounds is more effective for skin conditions is an active research question.

Read More on RethinkTHC

Cite This Study

RTHC-07963·https://rethinkthc.com/research/RTHC-07963

APA

Wolińska, Renata; Zalewska, Maria; Poznański, Piotr; Nawrocka, Agata; Kowalczyk, Agnieszka; Sacharczuk, Mariusz; Bujalska-Zadrożny, Magdalena. (2025). Anti-Inflammatory Activity of Cannabis sativa L. Extract in 2,4-Dinitrochlorobenzene-Induced Dermatitis in Rats.. Pharmaceuticals (Basel, Switzerland), 18(3). https://doi.org/10.3390/ph18030370

MLA

Wolińska, Renata, et al. "Anti-Inflammatory Activity of Cannabis sativa L. Extract in 2,4-Dinitrochlorobenzene-Induced Dermatitis in Rats.." Pharmaceuticals (Basel, 2025. https://doi.org/10.3390/ph18030370

RethinkTHC

RethinkTHC Research Database. "Anti-Inflammatory Activity of Cannabis sativa L. Extract in ..." RTHC-07963. Retrieved from https://rethinkthc.com/research/wolinska-2025-antiinflammatory-activity-of-cannabis

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.